It's too bad that Cytodyn picked Mortality as the end point.
This should have been tied to a health rating of some type.
Alive and on a vent, or Alive and on a wheel chair or alive and on supplemental oxygen equals alive and walking out of the hospital. This left results looking less clear than they should have been.
The new Brazil trials will be looking at whose walking out of the hospital.
Market Data 
Markets 
AI
